The management of schizophrenia: safety, treatment, and continuity of care. Introduction.

The management of schizophrenia: safety, treatment, and continuity of care. Introduction. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The management of schizophrenia: safety, treatment, and continuity of care. Introduction. Abstract Text:

John M Kane,John M Kane,

The management of schizophrenia: safety, treatment, and continuity of care. Introduction. Publishing Authors By Initials

JM Kane,JM Kane,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The management of schizophrenia: safety, treatment, and continuity of care. Introduction. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: CNS spectrums

VOLUME: 12

Page Numbers: 4

Journal Abbreviation:

ISSN: 1092-8529

DAY: 15

MONTH: Oct

YEAR: 2007

The management of schizophrenia: safety, treatment, and continuity of care. Introduction. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9702877

The management of schizophrenia: safety, treatment, and continuity of care. Introduction. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The management of schizophrenia: safety, treatment, and continuity of care. Introduction. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The management of schizophrenia: safety, treatment, and continuity of care. Introduction.

AFFILIATION: Behavioral Health Services, North Shore-Long Island Jewish Health System, NY, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: CNS Spectr

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The management of schizophrenia: safety, treatment, and continuity of care Introduction Related Publications

• 277.
• A modular, flexible training strategy to achieve competence in diagnostic and interventional musculoskeletal ultrasound in patients with hip osteoarthritis.
• A process to facilitate decision making in pediatric stem cell transplantation: the individualized care planning and coordination model.
• A role for N-cadherin in mesodermal morphogenesis during gastrulation.
• Advances and opportunities in assessing contaminant sensitivity of freshwater mussel (Unionidae) early life stages.
• Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor.
• Demonstration of complex-conjugate-resolved harmonic Fourier-domain optical coherence tomography imaging of biological samples.
• Diploids heterozygous for a vma13Delta mutation in Saccharomyces cerevisiae highlight the importance of V-ATPase subunit balance in supporting vacuolar acidification and silencing cytosolic V1-ATPase activity.
• Editorial: schizophrenia international research society.
• Effects of body mass on nicotine-induced thermogenesis and catecholamine release in male smokers.
• Genomics and the future of pharmacotherapy in psychiatry.
• Geriatrics as a paradigm for good chronic care.
• Head injury - modern army combatives: 999: may 30 2:40 PM - 3:00 PM.
• Integer quantum Hall effect on a six-valley hydrogen-passivated silicon (111) surface.
• Laparoscopic Nissen fundoplication in an infant with situs inversus.
• Loss of vacuolar proton-translocating ATPase activity in yeast results in chronic oxidative stress.
• Metabolic risks and effects of atypical antipsychotic treatment.
• National survey of pediatric residency program directors and residents regarding education in palliative medicine and end-of-life care.
• Patient-reported outcomes in end-of-life research in pediatric oncology.
• RAVE is essential for the efficient assembly of the C subunit with the vacuolar H(+)-ATPase.
• Radiation medicine practice in the image-guided radiation therapy era: new roles and new opportunities.
• Raftlike polyvalent inhibitors of the anthrax toxin: modulating inhibitory potency by formation of lipid microdomains.
• Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.
• SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells.
• Scaffolds based on degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell culture.
• Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid.
• The contributions of strategy use to working memory span: a comparison of strategy assessment methods.
• The management of schizophrenia: safety, treatment, and continuity of care. Introduction.
• Treatment adherence and long-term outcomes.
• Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity?